M, L., M, H., A, L., P, H., R, R., A, M., . . . L, S. (2026). Real-World Effectiveness and Safety of Tildrakizumab in a Large Spanish Multicenter Cohort from Spanish Psoriasis Group (GPS). Pharmacy (Basel, Switzerland), 14(3), . https://doi.org/10.3390/pharmacy14030063
Chicago Style (17th ed.) CitationM, Llamas-Velasco, et al. "Real-World Effectiveness and Safety of Tildrakizumab in a Large Spanish Multicenter Cohort from Spanish Psoriasis Group (GPS)." Pharmacy (Basel, Switzerland) 14, no. 3 (2026). https://doi.org/10.3390/pharmacy14030063.
MLA (9th ed.) CitationM, Llamas-Velasco, et al. "Real-World Effectiveness and Safety of Tildrakizumab in a Large Spanish Multicenter Cohort from Spanish Psoriasis Group (GPS)." Pharmacy (Basel, Switzerland), vol. 14, no. 3, 2026, https://doi.org/10.3390/pharmacy14030063.